Prevalence and clinical outcomes of viral and bacterial coinfections in hospitalized COVID-19 patients CDCgov ClinicalOutcomes ViralCoinfection BacterialCoinfection COVID19 SARSCoV2 Hospitalizations
By Dr. Chinta SidharthanMar 7 2023Reviewed by Aimee Molineux In a recent study published in Influenza and Other Respiratory Viruses, researchers analyzed the occurrence of bacterial and viral infections in adults hospitalized with coronavirus disease 2019 to determine the clinical and demographic features, outcomes, and microbial spectrums associated with bacterial coinfections and the prevalence of viral coinfections.
About the study In the present study, the researchers used data from a surveillance platform based on a geographically diverse large population from the United States known as Coronavirus Disease 2019-Associated Hospitalization Surveillance Network , which comprises data from 250 hospitals from 14 U.S. states.
Associations between having bacterial coinfections with SARS-CoV-2 infections and worse clinical outcomes, such as the need for mechanical ventilation, admission to intensive care units, or death, were analyzed. Furthermore, the study also compared demographic and clinical characteristics between patients who had and did not have bacterial coinfections. Additionally, the prevalence of viral coinfections or secondary infections was also calculated.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20-44 YearsThis study assesses the prevalence rates of cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, obesity, and tobacco use), treatment, and control among adults aged 20 to 44 years from 2009 through March 2020, overall and by sex and race and ethnicity.
Read more »
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning - Molecular MedicineBackground Survivors of acute COVID-19 often suffer prolonged, diffuse symptoms post-infection, referred to as “Long-COVID”. A lack of Long-COVID biomarkers and pathophysiological mechanisms limits effective diagnosis, treatment and disease surveillance. We performed targeted proteomics and machine learning analyses to identify novel blood biomarkers of Long-COVID. Methods A case–control study comparing the expression of 2925 unique blood proteins in Long-COVID outpatients versus COVID-19 inpatients and healthy control subjects. Targeted proteomics was accomplished with proximity extension assays, and machine learning was used to identify the most important proteins for identifying Long-COVID patients. Organ system and cell type expression patterns were identified with Natural Language Processing (NLP) of the UniProt Knowledgebase. Results Machine learning analysis identified 119 relevant proteins for differentiating Long-COVID outpatients (Bonferonni corrected P | 0.01). Protein combinations were narrowed down to two optimal models, with nine and five proteins each, and with both having excellent sensitivity and specificity for Long-COVID status (AUC = 1.00, F1 = 1.00). NLP expression analysis highlighted the diffuse organ system involvement in Long-COVID, as well as the involved cell types, including leukocytes and platelets, as key components associated with Long-COVID. Conclusions Proteomic analysis of plasma from Long-COVID patients identified 119 highly relevant proteins and two optimal models with nine and five proteins, respectively. The identified proteins reflected widespread organ and cell type expression. Optimal protein models, as well as individual proteins, hold the potential for accurate diagnosis of Long-COVID and targeted therapeutics.
Read more »
Trial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptomsTrial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptoms univ_spn COVID19 SARSCoV2 LongCOVID Vaccine Effectiveness
Read more »
Meta-analysis on COVID-19 vaccine effectiveness in association with antibody titersResearchers performed a meta-analysis analyzing randomized controlled trials (RCTs) that evaluated the effectiveness of coronavirus disease 2019 (COVID-19) vaccines, and the dose-response association of humoral responses with vaccine effectiveness.
Read more »
Loughborough lecturer launches exhibition to make sense of IVFEl Morgan, who gave birth to twins in 2019, says she used art to deal with the stress of IVF.
Read more »
Loughborough lecturer launches exhibition to make sense of IVFEl Morgan, who gave birth to twins in 2019, says she used art to deal with the stress of IVF.
Read more »